University City Science Center

QED Proof-of-Concept Program

The QED Program is a multi-institutional proof-of-concept program that provides business development support for academic researchers developing early-stage life science and healthcare IT technologies with high commercial potential.

The key goal is to retire the business risk in these early-stage projects, increasing their attractiveness to follow-on investment by established life science companies and private investors.

The QED Program integrates four elements that are critical to successfully and efficiently performing early-stage proof-of-concept technology development: business advice, bridge funding, market drivers and guidance to exit.

The QED Program currently includes the following network of research institutions:

  • The Children’s Hospital of Philadelphia
  • Delaware State University
  • Drexel University
  • Fox Chase Cancer Center
  • Harrisburg University of Science and Technology
  • Lankenau Institute for Medical Research
  • Lehigh University
  • Monell Chemical Senses Center
  • New Jersey Institute of Technology
  • The Pennsylvania State University
  • Philadelphia College of Osteopathic Medicine
  • Philadelphia University
  • Rowan University
  • Rutgers University
  • Temple University
  • Thomas Jefferson University
  • University of Delaware
  • University of Pennsylvania
  • University of the Sciences in Philadelphia
  • Widener University
  • The Wistar Institute

Other organizations are expected to be included in future funding cycles. If your organization is not a current participant, and would like to participate in the program, please contact us at